These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Immunopathology of the glomerular changes in chronic pyelonephritis. Yonezawa S Acta Pathol Jpn; 1979 Sep; 29(5):677-85. PubMed ID: 386707 [TBL] [Abstract][Full Text] [Related]
5. The variable pathology of kidney disease after liver transplantation. Kim JY; Akalin E; Dikman S; Gagliardi R; Schiano T; Bromberg J; Murphy B; de Boccardo G Transplantation; 2010 Jan; 89(2):215-21. PubMed ID: 20098285 [TBL] [Abstract][Full Text] [Related]
6. Immunopathology of the end-stage kidney. Immunoglobulin and complement component deposition in nonimmune disease. Velosa J; Miller K; Michael AF Am J Pathol; 1976 Jul; 84(1):149-62. PubMed ID: 779494 [TBL] [Abstract][Full Text] [Related]
7. Glomerulonephritis with mesangial deposits of IgA unassociated with systemic disease. Katz A; Underdown BJ; Minta JO; Lepow IH Can Med Assoc J; 1976 Feb; 114(3):209-15. PubMed ID: 801796 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus detection in kidney biopsy specimens correlates with glomerular mesangial injury. Iwama H; Horikoshi S; Shirato I; Tomino Y Am J Kidney Dis; 1998 Nov; 32(5):785-93. PubMed ID: 9820448 [TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin-A and the pathogenesis of schistosomal glomerulopathy. Barsoum R; Nabil M; Saady G; Genin C; Saleh E; Francis M; el-Kalioubi A; Iskander I; el-Garem A Kidney Int; 1996 Sep; 50(3):920-8. PubMed ID: 8872967 [TBL] [Abstract][Full Text] [Related]
14. Kidney glomerular pathology in various forms of acute and chronic hepatitis. Morzycka M; Slusarczyk J Arch Pathol Lab Med; 1979 Jan; 103(1):38-41. PubMed ID: 365129 [TBL] [Abstract][Full Text] [Related]
15. [Glomerular nephropathies treated with anticoagulants. Unusual course studied with immunofluorescence followed by repeated renal biopsies]. Meyrier A; Devergie A; Leroux-Robert C; Sraer JD; Richet G J Urol Nephrol (Paris); 1972 Sep; 78(9):738-40. PubMed ID: 4574092 [No Abstract] [Full Text] [Related]
16. Comprehensive evaluation of the significance of immunofluorescent findings on clinicopathological features in IgA nephropathy. Katafuchi R; Nagae H; Masutani K; Tsuruya K; Mitsuiki K Clin Exp Nephrol; 2019 Feb; 23(2):169-181. PubMed ID: 30066158 [TBL] [Abstract][Full Text] [Related]
17. Toward a working definition of C3 glomerulopathy by immunofluorescence. Hou J; Markowitz GS; Bomback AS; Appel GB; Herlitz LC; Barry Stokes M; D'Agati VD Kidney Int; 2014 Feb; 85(2):450-6. PubMed ID: 24067430 [TBL] [Abstract][Full Text] [Related]
18. Renal immunofluorescence and the prediction of renal outcome in patients with proliferative lupus nephritis. Nossent H; Berden J; Swaak T Lupus; 2000; 9(7):504-10. PubMed ID: 11035415 [TBL] [Abstract][Full Text] [Related]
19. Detection of immunoglobulin depositions by immunofluorescence and/or immunoperoxidase (P-AP method) in patients with IgA nephropathy. Miura M; Tomino Y; Nomoto Y; Sakai H; Osamura Y Tokai J Exp Clin Med; 1987 Dec; 12(5-6):343-7. PubMed ID: 3334190 [TBL] [Abstract][Full Text] [Related]
20. [Glomerular immunopathology: comparative study with immunofluorescence and immunoperoxidase (author's transl)]. Vieira LM; Sarno EN; Ruzany F; De Lacerda PR Rev Bras Pesqui Med Biol; 1979 Dec; 12(6):377-81. PubMed ID: 396606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]